Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats

Behavioural Brain Research

Volumn 233, Issue 2, 2012, Pages 526-535

  Della, Franciela P ^a   Abelaira, Helena M ^a   Réus, Gislaine Z ^a   Ribeiro, Karine F ^a   Antunes, Altamir R ^a   Scaini, Giselli ^a   Jeremias, Isabela C ^a   dos Santos, Lis Mairá M ^a   Jeremias, Gabriela C ^a   Streck, Emilio L ^a   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

BDNF; Depression; Energy metabolism; Forced swimming test; Tianeptine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CITRATE SYNTHASE; CREATINE KINASE; CYTOCHROME C OXIDASE; IMIPRAMINE; MALATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); TIANEPTINE; UBIQUINOL CYTOCHROME C REDUCTASE;

ACUTE TREATMENT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENERGY METABOLISM; ENZYME ACTIVITY; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; LONG TERM CARE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; THERAPY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CITRATE (SI)-SYNTHASE; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENERGY METABOLISM; EXPLORATORY BEHAVIOR; FREEZING REACTION, CATALEPTIC; IMIPRAMINE; MALE; RATS; RATS, WISTAR; SWIMMING; THIAZEPINES;

EID: 84862681768     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.039     Document Type: Article

References (67)

1. Jain R. The epidemiology and recognition of pain and physical symptoms in depression. Journal of Clinical Psychiatry 2009, 10.4088/JCP.8001tx1c.e04.
2. Rohde P., Beevers C.G., Stice E., O'Neil K. Major and minor depression in female adolescents: onset, course, symptom presentation, and demographic associations. Journal of Clinical Psychology 2009, 65:1339-1349.
3. Kinney D.K., Takana M. An evolutionary hypothesis of depression and its symptoms, adaptive value, and risk factors. Journal of Nervous and Mental Disease 2009, 197:561-567.
4. Larsen M.H., Mikkelsen J.D., Hay-Schmidt A., Sandi C. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. Journal of Psychiatric Research 2010, 44:808-816.
5. McEwen B.S., Magarinos A.M., Reagan L.P. Structural plasticity and tianeptine: cellular and molecular targets. European Psychiatry 2002, 17:318-330.
6. Wilde M.I., Benfield P. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 1995, 49:411-439.
7. Uzbekov M.G., Misionzhnik E.Y., Maximova N.M., Vertogradova O.P. Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of action. Human Psychopharmacology 2006, 21:109-115.
8. Pitra P., Tokarski K., Grzegorzewska M., Hess G. Effects of repetitive administration of tianeptine, zinc hydroaspartate and electroconvulsive shock on the reactivity of 5-HT(7) receptors in rat hippocampus. Pharmacological Reviews 2007, 59:627-635.
9. Brink C.B., Harvey B.H., Brand L. Tianeptine: a novel atypical antidepressant that may provide new insights into the biomolecular basis of depression. Recent Patents CNS Drug Discover 2006, 1:29-41.
10. Ansseau M. The paradox of tianeptine. European Psychiatry 1993, 8:89-93.
11. Kasper S. Neuroplasticity and the treatment of depression. Neuropsychiatric Disease and Treatment 2006, 2:15-20.
12. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006, 59:1116-1127.
13. Kanarik M., Matrov D., Koiv K., Eller M., Tonissaar M., Harro J. Changes in regional long-term oxidative metabolism induced by partial serotonergic denervation and chronic variable stress in rat brain. Neurochemistry International 2008, 52:432-437.
14. Stanyer L., Jorgensen W., Hori O., Clark J.B., Heales S.J. Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Neurochemistry International 2008, 53:95-101.
15. Calabrese V., Scapagnini G., Giuffrida-Stella A.M., Bates T.E., Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochemical Research 2002, 26:739-764.
16. Horn D., Barrientos A. Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life 2008, 60:421-429.
17. Feier G., Valvassori S.S., Rezin G.T., Búrigo M., Streck E.L., Kapczinski F., et al. Creatine kinase levels in patients with bipolar disorder: depressive, manic, and euthymic phases. Revista Brasileira de Psiquiatria 2011, 33:171-175.
18. Santos P.M., Scaini G., Rezin G.T., Benedet J., Rochi N., Jeremias G.C., et al. Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Research Bulletin 2009, 80:327-330.
19. Scaini G., Santos P.M., Benedet J., Rochi N., Gomes L.M., Borges L.S., et al. Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants. Brain Research Bulletin 2010, 82:224-227.
20. Rezin G.T., Gonçalves C.L., Daufenbach J.F., Fraga D.B., Santos P.M., Ferreira G.K., et al. Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Research Bulletin 2009, 79:418-421.
21. El Hage M., Baverel G., Martin G. Effects of valproate on glutamate metabolism in rat brain slices: a (13)C NMR study. Epilepsy Research 2006, [Epub ahead of print].
22. Marco R., Pestañna A., Sebastian J., Alberto S. Oxaloacetate metabolic crossroads in liver. Enzyme compartmentation and regulation of gluconeogenesis. Molecular and Cellular Biochemistry 1974, 3:53-70.
23. Rustin P., Munnich A., Rotig A. Succinate dehydrogenase and human diseases: new insights into a well-known enzyme. European Journal of Human Genetics 2002, 10:289-291.
24. Minárik P., Tomásková N., Kollárová M., Antalík M. Malate dehydrogenases-structure and function. General Physiology and Biophysics 2002, 21:257-265.
25. Morley-Fletcher S., Darnaudery M., Koehl M., Casolini P., Van Reeth O., Maccari S. Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Research 2003, 989:246-251.
26. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Barbosa L.M., Andreazza A.C., et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:140-144.
27. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Barbosa L.M., Andreazza A.C., et al. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic & Clinical Pharmacology & Toxicology 2008, 103:502-506.
28. Porsolt R.D., Le Pichon M., Jalfre M. Animal model of depression. Nature 1977, 266:730-732.
29. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
30. Paxinos G., Watson C. The Rat Brain: Stereotaxic Coordinates 1986, Academic Press, Australia. second ed.
31. Lowry O.H., Rosebough N.G., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
32. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Archives of Biochemistry and Biophysics 1996, 328:309-316.
33. Fischer J.C., Ruitenbeek W., Berden J.A., Trijbels J.M., Veerkamp J.H., Stadhouders A.M., et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clinica Chimica Acta 1985, 153:23-36.
34. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clinica Chimica Acta 1962, 7:597-604.
35. Shepherd D., Garland P.B. The kinetic properties of citrate synthase from rat liver mitochondria. Journal of Biochemistry 1969, 114:597-610.
36. Kitto G.B. Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods in Enzymology 1969, 13:106-116.
37. Warner-Schmidt J.L., Vanover K.E., Chen E.Y., Marshall J.J., Greengard P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Biological Psychiatry 2010, 68:528-535.
38. Solich J., Pałach P., Budziszewska B., Dziedzicka-Wasylewska M. Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter. Pharmacol Reviews 2008, 60:1008-1013.
39. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 2007, 18:391-418.
40. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
41. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology 2008, 11:1169-1180.
42. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008, 64:527-532.
43. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 2002, 22:3251-3261.
44. Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research 2005, 1037:204-208.
45. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biological Psychiatry 2006, 59:244-251.
46. Dias B.G., Banerjee S.B., Duman R.S., Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 2003, 45:553-563.
47. Altieri M., Marini F., Arban R., Vitulli G., Jansson B.O. Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Research 2004, 1000:148-155.
48. Kuroda Y., McEwen B.S. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Research. Molecular Brain Research 2008, 59:35-39.
49. Reagan L.P., Hendry R.M., Reznikov L.R., Piroli G.G., Wood G.E., McEwen B.S., et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. European Journal of Pharmacology 2007, 565:68-75.
50. Abelaira H.M., Réus G.Z., Ribeiro K.F., Zappellini G., Ferreira G.K., Gomes L.M., et al. Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats. Neurochemistry International 2011, 59:1163-1174.
51. Eisch A.J., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biological Psychiatry 2003, 54:994-995.
52. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. Journal of Neuroscience 2003, 23:742-747.
53. Narita M., Aoki K., Takagi M., Yajima Y., Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 2003, 119:767-775.
54. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. Journal of Neuroscience 1999, 19:4110-4122.
55. Shirayama Y., Chaki S. Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Current Neuropharmacology 2006, 4:277-291.
56. Réus G.Z., Stringari R.B., Ribeiro K.F., Ferraro A.K., Vitto M.F., Cesconetto P., et al. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behavioural Brain Research 2011, 221:166-171.
57. Fortunato J.J., Réus G.Z., Kirsch T.R., Stringari R.B., Fries G.R., Kapczinski F., et al. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. Journal of Neural Transmission 2010, 10:1131-1137.
58. Gardner A., Johansson A., Wibom R., Nennesmo I., von Döbeln U., Hagenfeldt L., et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. Journal of Affective Disorders 2003, 76:55-68.
59. Beasley C.L., Pennington K., Behan A., Wait R., Dunn M.J., Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006, 6:3414-3425.
60. Gardner A., Salmaso D., Nardo D., Micucci F., Nobili F., Sanchez-Crespo A., et al. Mitochondrial function is related to alterations at brain SPECT in depressed patients. CNS Spectrums 2008, 13:805-814.
61. Tanabe K., Masuda K., Hirayama A., Nagase S., Kono I., Kuno S. Effect of spontaneous exercise on antioxidant capacity in rat muscles determined by electron spin resonance. Acta Physiologica 2006, 186:119-125.
62. Benard G., Faustin B., Passerieux E., Galinier A., Rocher C., Bellance N., et al. Physiological diversity of mitochondrial oxidative phosphorylation. American Journal of Physiology 2006, 291:1172-1182.
63. Agostinho F.R., Réus G.Z., Stringari R.B., Ribeiro K.F., Ferraro A.K., Benedet J., et al. Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain. Neuroscience Letters 2011, 487:278-281.
64. Hroudova J., Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuroendocrinology Letters 2010, 3:336-342.
65. Assis L.C., Rezin G.T., Comim C.M., Valvassori S.S., Jeremias I.C., Zugno A.I., et al. Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Revista Brasileira de Psiquiatria 2009, 31:247-252.
66. Fattal O., Budur K., Vaughan A.J., Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 2006, 47:1-7.
67. Madrigal J.L., Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Rodrigo J., et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacol 2001, 24:420-429.